A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy

These findings highlight dIT's potential role in primary prophylaxis against MBM, with anti-PD1 as the likely workhorse agent. Prospective studies are warranted.